GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Infinium Pharmachem Ltd (NSE:INFINIUM) » Definitions » EV-to-EBITDA

Infinium Pharmachem (NSE:INFINIUM) EV-to-EBITDA : 22.60 (As of Jun. 30, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Infinium Pharmachem EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Infinium Pharmachem's enterprise value is ₹4,189 Mil. Infinium Pharmachem's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ₹185 Mil. Therefore, Infinium Pharmachem's EV-to-EBITDA for today is 22.60.

The historical rank and industry rank for Infinium Pharmachem's EV-to-EBITDA or its related term are showing as below:

NSE:INFINIUM' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.74   Med: 16.88   Max: 24.83
Current: 22.6

During the past 6 years, the highest EV-to-EBITDA of Infinium Pharmachem was 24.83. The lowest was 8.74. And the median was 16.88.

NSE:INFINIUM's EV-to-EBITDA is ranked worse than
65.42% of 1281 companies
in the Chemicals industry
Industry Median: 14.06 vs NSE:INFINIUM: 22.60

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-30), Infinium Pharmachem's stock price is ₹290.50. Infinium Pharmachem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹5.600. Therefore, Infinium Pharmachem's PE Ratio (TTM) for today is 51.88.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Infinium Pharmachem EV-to-EBITDA Historical Data

The historical data trend for Infinium Pharmachem's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Infinium Pharmachem EV-to-EBITDA Chart

Infinium Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EV-to-EBITDA
Get a 7-Day Free Trial - - - 15.92 17.93

Infinium Pharmachem Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only - - 15.92 - 17.93

Competitive Comparison of Infinium Pharmachem's EV-to-EBITDA

For the Chemicals subindustry, Infinium Pharmachem's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Infinium Pharmachem's EV-to-EBITDA Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Infinium Pharmachem's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Infinium Pharmachem's EV-to-EBITDA falls into.


;
;

Infinium Pharmachem EV-to-EBITDA Calculation

Infinium Pharmachem's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4189.294/185.364
=22.60

Infinium Pharmachem's current Enterprise Value is ₹4,189 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Infinium Pharmachem's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ₹185 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Infinium Pharmachem  (NSE:INFINIUM) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Infinium Pharmachem's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=290.50/5.600
=51.88

Infinium Pharmachem's share price for today is ₹290.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Infinium Pharmachem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹5.600.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Infinium Pharmachem EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Infinium Pharmachem's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Infinium Pharmachem Business Description

Traded in Other Exchanges
N/A
Address
V.U. Nagar GIDC Road, Near Sardar Patel Statue, Suite 205, Sigma Prime, 2nd Floor, District Anand, Vallabh Vidhyanagar, GJ, IND, 388120
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.

Infinium Pharmachem Headlines

No Headlines